First Page | Document Content | |
---|---|---|
Date: 2016-05-25 01:37:50Clinical medicine Medicine Antineoplastic drugs Breakthrough therapy Pharmacology Bristol-Myers Squibb Monoclonal antibodies Immune system Programmed cell death protein 1 Nivolumab Pharmac Pembrolizumab | 24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO BoxAdd to Reading ListSource URL: www.nzma.org.nzDownload Document from Source WebsiteFile Size: 204,92 KBShare Document on Facebook |
Breakthrough Cancer Therapy DTCDocID: 1sYyU - View Document | |
Microsoft Word - GILEAD BRIEFINGDocID: 1r2Vm - View Document | |
Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatioDocID: 1qWZQ - View Document | |
24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO BoxDocID: 1qVSm - View Document | |
12-AUG:10 CANCER CONTROL ACCRUAL REPORT STUDY ODocID: 1qRuM - View Document |